Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 50, Issue 3, Pages 438-443
Publisher
Springer Nature
Online
2015-01-20
DOI
10.1038/bmt.2014.286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate
- (2012) J. A. Perez-Simon et al. HAEMATOLOGICA
- Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
- (2012) Mitsutoshi Kurosawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
- (2012) Takehiko Mori et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection
- (2010) J. L. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
- (2010) Dimitrios P. Kontoyiannis et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
- (2009) Vincent T. Ho et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defining the Intensity of Conditioning Regimens: Working Definitions
- (2009) Andrea Bacigalupo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) I. Amigues et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring
- (2009) S M Trifilio et al. BONE MARROW TRANSPLANTATION
- Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients
- (2009) M Mikulska et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges
- (2009) Ronen Ben-Ami et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections
- (2009) Jane A Cecil et al. Expert Review of Hematology
- In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2008) C. Lass-Florl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients
- (2008) P. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sirolimus, Tacrolimus, and Low-Dose Methotrexate as Graft-versus-Host Disease Prophylaxis in Related and Unrelated Donor Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
- (2008) Edwin P. Alyea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
- (2008) D. Neofytos et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
- (2008) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Concurrent Administration of Sirolimus and Voriconazole: A Pilot Study Assessing Safety and Approaches to Appropriate Management
- (2008) Dorothy Surowiec et al. PHARMACOTHERAPY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search